July 19, 2021 04:51 AM EDTUpdated 05:56 AM

Tillman Gerngross is betting well over $500M that the pandemic will never really end. Here’s the IPO pitch

Tillman Gerngross doesn’t waffle.

The longtime Dartmouth professor and Adimab founder tends to pick a course and drive straight for the goal. If he sees …

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

TRENDING NOW

Till­man Gern­gross is bet­ting well over $500M that the pan­dem­ic will nev­er re­al­ly end. Here’s the IPO pitch